Cytarabine 61703-0304-36

Package NDC

61703-0304-36

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: February 28, 1994
Listing Expires: December 31, 2026
Application: ANDA072945

Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cytarabine	20 mg/mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

61703-0304-36Selected

1 VIAL, MULTI-DOSE in 1 CARTON (61703-304-36) / 25 mL in 1 VIAL, MULTI-DOSE